Champlain Investment Partners, LLC Genetron Holdings LTD Transaction History

Champlain Investment Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$17.9 - $23.29 $775,338 - $1.01 Million	-43,315 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$13.71 - $30.64 $125,857 - $281,275	-9,180 Reduced 17.49%	43,315 $930,000
Q4 2020 Feb 12, 2021	BUY	$9.31 - $14.0 $112,185 - $168,700	12,050 Added 29.79%	52,495 $735,000
Q3 2020 Nov 13, 2020	BUY	$9.1 - $15.81 $140,549 - $244,185	15,445 Added 61.78%	40,445 $483,000
Q2 2020 Aug 13, 2020	BUY	$11.29 - $16.0 $282,250 - $400,000	25,000 New	25,000 $302,000

7.5K

Ticker GTH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 90,602,304
Description
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...

Get notified when there are updates to the investment portfolio of Champlain Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Champlain Investment Partners, LLC with notifications on news.